Please turn JavaScript on
header-image

BIOTECanada

Subscribe to BIOTECanada’s news feed.

Click on “Follow” and decide if you want to get news from BIOTECanada via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to BIOTECanada comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from BIOTECanada which you are really interested in. Click on the blue “Filter” button below to get started.

Website title: Home - BIOTECanada

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.09 / day

Message History

BIOTECanada welcomes the launch of the National Research Council of Canada’s Biomedical Countermeasures Initiative, introduced as part of the federal government’s Defence Industrial Strategy. It is an important step in strengthening Canada’s domestic capacity to develop and manufacture diagnostics, vaccines, and therapeutics, and help move biomedical innovation into real-worl...


Read full story

The Canadian Genomics Strategy (CGS) Secretariat, Global Affairs Canada (GAC) through the Consulate General of Canada in Boston, and working with Genome Canada, are pleased to organize a genomics trade mission to Boston during the first week of June 2026.

Canadian genomics companies chosen to be part of the Canadian delegation will benefit from cura...


Read full story

MISSISSAUGA, ON, March 2, 2026 /CNW/ – Alnylam Canada ULC is pleased to announce it has received a positive recommendation from Canada’s Drug Agency (CDA) for the public reimbursement of its RNAi therapeutic, AMVUTTRA®.1 In December 2025, AMVUTTRA® was authorized by Health Canada for the treatment of cardiomyopathy in adult patients with wild...


Read full story
Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseases HS235 offers potential to treat pulmonary hypertension (PH) patients while reducing the risk of bleeding and providing unique metabolic benefits compared to existing therapies

Montreal, QC, Canada (Feb 25, 2026)...


Read full story

BIOTECanada welcomes the launch of Canada’s Defence Industrial Strategy, and the recognition of life sciences as part of Canada’s broader security, innovation, and economic agenda by Prime Minister Mark Carney earlier today.

The strategy’s emphasis on strengthening the generation and sovereign control of Canadian IP, securing supply chains, investing in defence and ...


Read full story